Naim Shehadeh

Efron St
Haifa, HA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Impact of Autoimmune Hypothyroidism and Celiac Disease on Progression to Diabetes in Individuals Positive for GAD65 or IA-2 Autoantibodies.

Impact of Autoimmune Hypothyroidism and Celiac Disease on Progression to Diabetes in Individuals Positive for GAD65 or IA-2 Autoantibodies.

Journal: Diabetes, obesity & metabolism

Published: April 13, 2026

Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease.

Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease.

Journal: Journal of clinical medicine

Published: October 13, 2025

The effect of oral l-arginine alone or in combination with sodium butyrate on glucagon-like peptide-1 secretion in non-diabetic adults with obesity.

The effect of oral l-arginine alone or in combination with sodium butyrate on glucagon-like peptide-1 secretion in non-diabetic adults with obesity.

Journal: Nutrition and health

Published: July 07, 2025

Treatment of Youth-Onset Type 2 Diabetes: Focus on SGLT-2 Inhibitor Use.

Treatment of Youth-Onset Type 2 Diabetes: Focus on SGLT-2 Inhibitor Use.

Journal: Pediatric diabetes

Published: June 27, 2025

Glucagon-like peptide-1 receptor agonists in adults with cystic fibrosis-related diabetes: Rationale and emerging evidence.

Glucagon-like peptide-1 receptor agonists in adults with cystic fibrosis-related diabetes: Rationale and emerging evidence.

Journal: Diabetes, obesity & metabolism

Published: April 06, 2025

Clinical and biochemical profile of individuals with renal glucosuria: A matched cohort study.

Clinical and biochemical profile of individuals with renal glucosuria: A matched cohort study.

Journal: Diabetes, obesity & metabolism

Published: January 18, 2025

Analysis and Visualization of Confounders and Treatment Pathways Leading to Amputation and Non-Amputation in Peripheral Artery Disease Patients Using Sankey Diagrams: Enhancing Explainability.

Analysis and Visualization of Confounders and Treatment Pathways Leading to Amputation and Non-Amputation in Peripheral Artery Disease Patients Using Sankey Diagrams: Enhancing Explainability.

Journal: Biomedicines

Published: December 25, 2024

Dapagliflozin or saxagliptin in pediatric type 2 diabetes: a plain language summary.

Dapagliflozin or saxagliptin in pediatric type 2 diabetes: a plain language summary.

Journal: Current medical research and opinion

Published: November 07, 2024

GLP-1 Receptor Agonist Therapy in Cystic Fibrosis-Related Diabetes: A Case Report.

GLP-1 Receptor Agonist Therapy in Cystic Fibrosis-Related Diabetes: A Case Report.

Journal: Diabetes technology & therapeutics

Published: October 03, 2024

Apelin and Myostatin Levels in Adolescents With Type-1-Diabetes.

Apelin and Myostatin Levels in Adolescents With Type-1-Diabetes.

Journal: Pediatric diabetes

Published: September 06, 2024

GLP-1 receptor agonists may enhance the effects of desmopressin in individuals with AVP deficiency: a case series and proposed mechanism.

GLP-1 receptor agonists may enhance the effects of desmopressin in individuals with AVP deficiency: a case series and proposed mechanism.

Journal: Pituitary

Published: August 23, 2024

Safety, Growth, and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up).

Safety, Growth, and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up).

Journal: The Journal of clinical endocrinology and metabolism

Published: August 02, 2024

Showing 1-12 of 80

Last Updated: 09/26/2026